Deardorf Caren 4
4 · Crinetics Pharmaceuticals, Inc. · Filed Jun 21, 2022
Insider Transaction Report
Form 4
Deardorf Caren
Director
Transactions
- Award
Stock Option (right to buy)
2022-06-17+4,375→ 4,375 totalExercise: $18.29Exp: 2032-06-16→ Common Stock (4,375 underlying)
Footnotes (1)
- [F1]The entire number of shares subject to this option become fully vested and exercisable on the first to occur of (a) the first anniversary of the grant date or (b) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service on the board of directors of the Issuer through such vesting date.